Education

• Ph.D., Pharmaceutical Sciences (University of Bradford in U.K., 1992)
• B.S., Pharmacy (University of Bradford in U.K., 1989)

Post-Graduate Training

• Post Doctoral Fellow - Pharmaceutics (Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, 1994)

Academic Appointments/Professional Experience

• 1997-Present. Research Associate Professor, Department of Pharmaceutics, Virginia Commonwealth University
• 1995-1996. Lecturer, Department of Pharmaceutical Sciences, University of Bradford, Bradford, U.K.

Research Interests

• Novel aerosol drug delivery devices
• In vitro particle size analysis
• Aerosol characterization and inhaler design

The publications search is performed on the National Library of Medicine's PubMed database. The search may be slow during high traffic hours, may return articles authored by another researcher with a similar name and may not always find all of a researcher's articles.

Publications

Books/Book Chapters

• Hindle M: “Aerosol Drug Delivery”. In: Pharmaceutical Manufacturing Handbook (Eds Gad SC). John Wiley and Sons Inc., Hoboken, NJ, ISBN: 978-0-471-21391-8, pp 683-728, 2008.
Patents

• Hindle, M and Cox, K.A., “Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating insulin aerosols”, US Patent # 7,683,029. Issued 2010.
• Byron PR, Hindle M: “Method and Apparatus for Generating an Aerosol”, US Patent # 7,128,067 B2 Issued 2006.
• Hindle M, Byron PR and Gupta R: “Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution,” United States Patent 6,883,516, 2005.
Recent Publications

• Tian, G., Longest, P.W., Su, G., Walenga, R.L. and Hindle, M. Development of a stochastic individual path (SIP) model for predicting the tracheobronchial deposition of pharmaceutical aerosols: Effects of transient inhalation and sampling the airways. J. Aerosol Sci. 2011; 42: 781-799.
• Longest, P. W. and Hindle, M. Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols. Aerosol Sci. Technol. 2011: 45: 874-889
• Longest, P.W., Tian, G. and Hindle, M. Improving the lung delivery of nasally administered aerosols during noninvasive ventilation – an application of enhanced condensational growth (ECG). J. Aerosol Med. Pulm Drug Del. 2011; 24(2): 103-118.
• Tian, G., Longest, P.W., Su, G. and Hindle, M. Evaluation of enhanced condensational growth (ECG) for respiratory drug delivery in a realistic mouth-throat and tracheobronchial individual path model. Ann. Biomed. Eng. 2011; 39 (3) 1136-1153
• Hindle, M. and Longest, P.W. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model. Pharm. Res., 2010; 27: 1800-1811
• Longest, P.W. and Hindle, M. CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data. J. Aerosol. Sci., 2010; 41: 805-820.
• Longest, P.W., McLeskey, J.T. and Hindle, M. Characterization of nanoaerosol size change during enhanced condensational growth, Aerosol Science and Technology, 2010; 44: 473-483.
• Longest, P.W. and Hindle, M. Quantitative analysis and design of a spray aerosol inhaler. Part 1: Effects of dilution air inlets and flow paths. J. Aerosol Med. Pulm Drug Del. 2009; 22(3): 271-283.
• Longest, P.W. and Hindle, M. Evaluation of the Respimat Soft Mist Inhaler using a Concurrent CFD and In Vitro Approach. J. Aerosol Med. Pulm Drug Del. 2009; 22: 99-112.